Melola Discovery

← Melola Discovery

Jurnal SINTA 1

INDIVIDUALISED DOSE OF GENTAMYCIN BASED ON CLINICAL PHARMACOKINETICS. A STUDY OF PROPHYLACTIC ANTIBIOTIC USAGE IN HEAD AND NECK SURGERY

Folia Medica Indonesiana · Vol. 39 No. 3 (2003)

ISSN
2355-8393, 2599-056X
Terbit
2003-07-01
Penerbit
Airlangga University
Bahasa
en

Abstrak

Twenty patients, age of 18-65 years, mean 43.10 years, with normal serum creatine underwent clean contaminated head & neck surgery was divided into two groups. Group I represented those who fit for all dose (80 mg) and group II consisted of those with individualized dose. In both groups gentamycin was administered ½ -1 hour before skin incision. In both groups serum levels of gentamycin were calculated at hour 1 and hour 4 post administration. The gentamycin level of each group were compared, and analyzed by the use of t and F tests. The serum level of gentamycin in 1 hour post administration varied between 2.51 - 6.46 ug/ml (mean 4.366ug/ml) in group I and 3.85 - 5.23 ug/ml (mean 4.558 ug/ml) in group II, variability of gentamycin serum level concentration hour-1 in group I was significantly wider than in group II (F>3.18). The gentamycin serum concentration hour-4 was 1.51 -2.97 ug/ml (mean 2.0l ug/ml) and 1.16-2.39 ug/ml (mean 1.70 ug/ml) in group I and group II respectively, there was no significant difference of variability between the two groups and those gentamycin serum concentrations were still effective as prophylactic antibiotic. The drug side effect monitoring by measuring the serum creatine pre and post operatively for all patients showed that there was no increasing of serum creatine more than 0.5mg/dL. We conclude that with the individualized regimen dose we could ascertain and calculate the effective dose of gentamycin for prophylaxis in surgery, it would give more constant serum concentration especially in hour-1 post administration when the surgery is started, and the serum concentration hour-4 was still effective as prophylactic antibiotic. The individualized regimen dose of entamycin will be safe for the patient because the dose calculation is based on the clinical pharmacokinetic parameters.

Kata kunci

Jaringan kolaborasi para penulis

9 penulis · 12 tautan kepenulisan bersama

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Mohammad Saiful IslamUniversitas Airlangga1
Adeltrudis AdelsaAfiliasi tidak diketahui1
Yan Efrata SembiringUniversitas Airlangga1
Tulus PanuwunAfiliasi tidak diketahui1
Tjahjo WinantyoAfiliasi tidak diketahui1
Indrayana NsAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">INDIVIDUALISED DOSE OF GENTAMYCIN BASED ON CLINICAL PHARMACOKINETICS. A STUDY OF PROPHYLACTIC ANTIBIOTIC USAGE IN HEAD AND NECK SURGERY</dc:title><dc:creator>Sunarto Reksoprawiro</dc:creator><dc:creator>Ruddy Hartono</dc:creator><dc:creator>Siti Sjamsiah</dc:creator><dc:subject>gentamicin</dc:subject><dc:subject>individualized dosing</dc:subject><dc:subject>antibiotic prophylaxis</dc:subject><dc:subject>head and neck surgery</dc:subject><dc:subject>clinical pharmacokinetics</dc:subject><dc:subject>serum drug concentration</dc:subject><dc:subject>clean-contaminated surgery</dc:subject><dc:subject>serum creatinine</dc:subject><dc:description xml:lang="en">Twenty patients, age of 18-65 years, mean 43.10 years, with normal serum creatine underwent clean contaminated head &amp; neck surgery was divided into two groups. Group I represented those who fit for all dose (80 mg) and group II consisted of those with individualized dose. In both groups gentamycin was administered ½ -1 hour before skin incision. In both groups serum levels of gentamycin were calculated at hour 1 and hour 4 post administration. The gentamycin level of each group were compared, and analyzed by the use of t and F tests. The serum level of gentamycin in 1 hour post administration varied between 2.51 - 6.46 ug/ml (mean 4.366ug/ml) in group I and 3.85 - 5.23 ug/ml (mean 4.558 ug/ml) in group II, variability of gentamycin serum level concentration hour-1 in group I was significantly wider than in group II (F&gt;3.18). The gentamycin serum concentration hour-4 was 1.51 -2.97 ug/ml (mean 2.0l ug/ml) and 1.16-2.39 ug/ml (mean 1.70 ug/ml) in group I and group II respectively, there was no significant difference of variability between the two groups and those gentamycin serum concentrations were still effective as prophylactic antibiotic. The drug side effect monitoring by measuring the serum creatine pre and post operatively for all patients showed that there was no increasing of serum creatine more than 0.5mg/dL. We conclude that with the individualized regimen dose we could ascertain and calculate the effective dose of gentamycin for prophylaxis in surgery, it would give more constant serum concentration especially in hour-1 post administration when the surgery is started, and the serum concentration hour-4 was still effective as prophylactic antibiotic. The individualized regimen dose of entamycin will be safe for the patient because the dose calculation is based on the clinical pharmacokinetic parameters.</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2003-07-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>http://journal.unair.ac.id/filerPDF/07%20SunartoE.pdf</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 39 No 3 (2003)</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language></oai_dc:dc>